Key points are not available for this paper at this time.
Pain is expensive. The National Academy of Sciences estimated in 2010 that more than 100 million American individuals experienced chronic unrelieved pain. The cost of pain was more than that of heart disease and cancer treatments. What if we had a pain treatment modality that improved pain and cost less?
Smith et al. (Fri,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: